Auron Therapeutics secures FDA clearance & $27M Series B to advance precision oncology

Booster Therapeutics launches with $15 M seed financing led by Apollo Health Ventures and Novo Holdings

HAYA Therapeutics enters partnership with Eli Lilly worth up to $1 B to discover new genome targets for obesity and related metabolic conditions

GSK enters into a multi-year data licence agreement with Ochre Bio

HAYA Therapeutics Co-Founders Win Inaugural Andreas & Thomas Struengmann Award

Ochre Bio Signs $1 B Deal with Boehringer Ingelheim to Develop Liver Disease Drugs

Aeovian Pharmaceuticals Closes $50 Million Follow-On Round and Moves Towards Human Clinical Trials

Auron Selects First Development Candidate from its Novel AURIGIN™ Platform